MOBY P1 exceeds typical hospital requirements for isolation wards and operating theaters—an essential factor in controlling the spread of infectious diseases.
While most hospitals only require ISO Class 5 cleanrooms, MOBY P1 achieves Class 2, comparable to the stringent environments NASA uses to assemble spacecraft. Furthermore, it is certified as a Class I medical device under the Medical Device Regulation (EU MDR), reflecting its exceptional quality and safety.
MOBY P1 can help improve outcomes under strict isolation protocols by making safe intra-hospital transport, emotional support, and participation in life possible. Because together, we get better.
In acute care settings, medical isolation leads to 17% longer stays, 23% higher costs, and higher readmission rates. MOBY P1 is the world’s first mobile protective vehicle created to secure freedom and human contact, even in the most precarious of medical situations.
Complete pathogen protection is achieved with dual HEPA filters inside and outside, operating under positive and negative pressure – to protect either the occupant or the surroundings. MOBY P1’s secure closure is both air and gas-tight.
When the canopy is closed, a 360-degree view is maintained. The zero-blind-spot interior is designed for fast and easy disinfection.
MOBY P1 comes with an electric motor capable of both active and passive drive, enabling anyone to drive or be driven in MOBY P1 smoothly.
Several modular access ports allow invertible gloves or device modules like patient monitors to be installed. While using MOBY P1, treatment can be continued – even direct touch with patients is possible.
A digital intercom transports sound naturally both ways. Clear communication without any restriction vision, speech, or touch creates the closest thing to normal, in-person interaction.
Several seat cushions for different heights create comfortable seating. Vertical hinged opening allows for easy entrance and exit, with dual-side assistance if necessary.
Length: 1580 mm
Width: 850 mm
Height: 1780 mm
Weight, net: 205 kg
Max. weight of passenger: 150 kg
Max. speed indoor 6 km/h
Ascent / descent: max. 3%
Power, nominal 2 x 200W
Brake system
Electromagnetic
Battery: 2 x 12VDC 30 Ah lead gel
Rear wheel diameter: 315 mm
Rear wheel tyre width: 90 mm
Front wheel diameter: 265 mm
Front wheel width: 90 mm
Attendant: Master joystick on rear handlebar
Passenger: Joystick inside
Ventilation and audio control: Touch screens for passenger and attendant
3-stage-filtering (HEPA H13, glass fibre retainer, G3)
Base flow rate: 300 l/min
Selectable, optional flow rates: 550 l/min, 800 l/min
Pressure type: Positive or Negative
Immunosupressive therapy patients
All organ transplantations
Bone marrow transplants
Intensive care stays
Cancer treatment
Burn unit
End of life care
Kidney dialysis
Care and visits of highly infectious patients (Tuberculosis, covid etc.)
Flash isolation of infectious patients
ER isolation
Efficient use of hospital rooms
Reduction in patient-staff pathogen transmission
Reduction in patient-staff pathogen transmission
At home isolation (for example due to asthma, diabetes)
A cost effective solution for any other cases where an isolation room is required
In October 2024, our groundbreaking MOBY P1 was first deployed at Charité Hospital’s pediatric oncology department in Berlin. Children undergoing bone marrow transplants often face lengthy isolation—40 to 50 days or more—making social interaction nearly impossible. By providing a sterile, mobile environment, MOBY P1 lets these young patients safely leave their wards, easing both emotional and logistical challenges.
In the following months, many families benefitted. A six-year-old patient was even able to meet her sister outside the ward—a visit that would otherwise have been impossible. Seeing her immediate boost in well-being underscored how MOBY P1 transforms medical isolation and offers hospitals worldwide a vital tool for safe patient mobility and social interaction.
In Summer 2023, we will begin a trial in collaboration with Charité, a world-renowned top 10 hospital. The trial will focus on their pediatric oncology department, specifically targeting children who have undergone bone marrow transplants. By using MOBY, medically isolated patients can safely leave the ward and receive visitors. We aim to positively impact a patient's quality of life leading to better long term outcomes including lower likelihood of development disorders, anxiety, and depression.